This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Sensitivity and specificity

Authoring team

These are statistical terms that are often confused. These terms can be illustrated by way of an example:

At a particular hospital a MIBG scanner is used to detect phaeochromocytomas. A positive scan was reported in 38 cases. An audit showed:

  • true positive (TP) 10, true negative (TN) 25,
  • false positive (FP) 0, false negative (FN) 3

where:

  • patients with phaeochromocytoma TP (person with a phaeochromocytoma and positive test)
  • patients with phaeochromocytoma FN (person with a phaeochromocytoma and negative test)
  • patients without phaeochromocytoma FP (person without a phaeochromocytoma with a positive test)
  • patients without a phaeochromocytoma TN (person without a phaeochromoytoma with a negative test)





phaeochromocytoma present

phaeochromyctoma absent

test result positive

TP = 10

test result positive

FP = 0

test result negative

FN = 3

test result negative

TN = 25

  • sensitivity = 100xTP /(TP+FN) = 100 x 10(10 + 3) = 77%
    • i.e. proportion of people with a phaeochromocytoma who are corectly identified by the screening test = 77%

  • specificity = 100xTN /(TN+FP) = 100 x 25 /(25+0) = 100%
    • i.e. proportion of people without phaeochromocytoma who have had a negative test result = 100%

  • positive predictive value = 100xTP/(TP+FP) = 100 x 10/(10+0) = 100%

i.e. the proportion of screening tests that are correct.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.